-The Hindu A computerised database of ration card holders and purchases is a safeguard against diversion of PDS supplies but the process can be disruptive for beneficiaries The government has initiated an interesting pilot for the Public Distribution System (PDS) in East Godavari, Andhra Pradesh. When cardholders go to buy their PDS rations, their ration card number and UID (Unique Identification) number are punched into an "e-Point of Sale" (ePOS) machine. If...
More »SEARCH RESULT
Total Matching Records found : 294
A cry in the dark -Esha Roy
-The Indian Express She was gangraped by 16 boys, nine of them juveniles. She was beaten, cut up and her genitals mutilated. She made it to hospital, but was sent home with first-aid. When she survived to fight, she ran into an indifferent administration and influential accused. Schools denied her admission, and others mocked and threatened her. Chances are you haven't heard this 16-year-old's story. Three days after the brutal attack on...
More »Finally, the patients prevail -Sarah Hiddleston
-The Hindu The Supreme Court has denied Novartis a patent for its anti-cancer drug Gleevec. This leaves the door open for Indian pharmaceutical companies to produce their own versions of the drug. Since these are sold at roughly one tenth of the patented brand price, for thousands of cancer patients it means the difference between medicine and no medicine at all. It is not just cancer patients that will benefit, but...
More »Patent justice-Sakthivel Selvaraj
-The Hindu Drug patents are designed to create profits that enable more research on diseases affecting millions. But in practice, they have often generated super profits for big pharma companies while erecting access barriers for the poor. The Novartis case spotlights much that is wrong with the system. The rejection of the Novartis petition challenging one of the most progressive tenets of the Indian Patents Act (1970), as amended in 2005 by...
More »Novartis patent ruling a victory in battle for affordable medicines-Sarah Boseley
-The Guardian Had Novartis won, it would have set a precedent for patenting of other medicines in India, delaying their reaching the poor The battle for affordable, life-saving medicines for poor countries was once waged on first-world city streets with banners and placards. But for some years now it has been a long-hard legal slog in offices and courtrooms. A decade or so ago, it was mostly about access to Aids drugs. Firms...
More »
